Pioneering the next generation of treatment solutions
We support innovation across the continuum of care, to help to develop new technologies, treatments and vaccines.
-
The new Ebola clinical trial that’s focused on helping halt future outbreaks
A groundbreaking partnership between countries, health organizations and companies worldwide—including Johnson & Johnson—hopes to find the most promising vaccines to help protect people from the virus.
Featured stories
-
-
Janssen Wins Prestigious International Prix Galien Award for MDR-TB Treatment
Ground breaking therapy offers hope for people with Multi-Drug Resistant Tuberculosis (MDR-TB)
More from Johnson & Johnson
-
Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health
Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 26 years since it entered the market, this groundbreaking device has helped more than 450,000 patients recover from heart injuries. -
Inside the development of Johnson & Johnson’s OTTAVA™ Robotic Surgical System
Built to expand OR capacity, maintain procedural momentum and elevate performance, OTTAVA™ is opening new possibilities in surgery. Neda Cvijetic, Global Head of Robotics & Digital R&D, MedTech at Johnson & Johnson, explains what surgeons need to know. -
The science behind targeted oral peptides
A new type of medication is tackling a problem that has long frustrated drug developers: how to deliver peptide therapies orally and hit their target more precisely.
